Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Long-Term Debt Issuances (2016 - 2025)

Nutex Health (NUTX) has disclosed Long-Term Debt Issuances for 11 consecutive years, with -$273000.0 as the latest value for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$273000.0; the TTM value through Mar 2026 reached -$157000.0, down 103.69%, while the annual FY2024 figure was $7.0 million, 42.87% up from the prior year.
  • Long-Term Debt Issuances hit -$273000.0 in Q4 2025 for Nutex Health, down from $15000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $13.9 million in Q2 2021 and bottomed at -$16.1 million in Q3 2023.
  • Average Long-Term Debt Issuances over 5 years is $1.7 million, with a median of $2.1 million recorded in 2024.
  • Year-over-year, Long-Term Debt Issuances surged 4561.66% in 2021 and then tumbled 405.35% in 2023.
  • Nutex Health's Long-Term Debt Issuances stood at $4.6 million in 2021, then plummeted by 300.5% to -$9.3 million in 2022, then skyrocketed by 143.17% to $4.0 million in 2023, then crashed by 47.75% to $2.1 million in 2024, then crashed by 113.0% to -$273000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at -$273000.0, $15000.0, and $101000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.